129 related articles for article (PubMed ID: 21986170)
1. Persistent carcinoma in cervical cancer screening: non-participation is the most significant cause.
Marquardt K; Büttner HH; Broschewitz U; Barten M; Schneider V
Acta Cytol; 2011; 55(5):433-7. PubMed ID: 21986170
[TBL] [Abstract][Full Text] [Related]
2. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
Marquardt K; Stubbe M; Broschewitz U
Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
[TBL] [Abstract][Full Text] [Related]
3. Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening.
Rossi PG; Caroli S; Mancini S; de' Bianchi PS; Finarelli AC; Naldoni C; Bucchi L; Falcini F;
Eur J Cancer Prev; 2015 Mar; 24(2):128-34. PubMed ID: 24787379
[TBL] [Abstract][Full Text] [Related]
4. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
[TBL] [Abstract][Full Text] [Related]
5. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization.
Nishimura M; Miyatake T; Nakashima A; Miyoshi A; Mimura M; Nagamatsu M; Ogita K; Yokoi T
Asian Pac J Cancer Prev; 2015; 16(18):8145-7. PubMed ID: 26745052
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening and analysis of potential risk factors in 43,567 women in Zhongshan, China.
Wang Y; Yu YH; Shen K; Xiao L; Luan F; Mi XJ; Zhang XM; Fu LH; Chen A; Huang X
Asian Pac J Cancer Prev; 2014; 15(2):671-6. PubMed ID: 24568476
[TBL] [Abstract][Full Text] [Related]
8. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
[TBL] [Abstract][Full Text] [Related]
10. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
11. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
[TBL] [Abstract][Full Text] [Related]
12. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
[TBL] [Abstract][Full Text] [Related]
13. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
15. Reasons for cervical cancer despite extensive screening.
Stenkvist B; Söderström J
J Med Screen; 1996; 3(4):204-7. PubMed ID: 9041486
[TBL] [Abstract][Full Text] [Related]
16. Tubal ligation frequency in Oklahoma women with cervical cancer.
Mathews CA; Stoner JA; Wentzensen N; Moxley KM; Tenney ME; Tuller ER; Myers T; Landrum LM; Lanneau G; Zuna RE; Gold MA; Wang SS; Walker JL
Gynecol Oncol; 2012 Nov; 127(2):278-82. PubMed ID: 22858904
[TBL] [Abstract][Full Text] [Related]
17. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears.
Rha SH; Dong SM; Jen J; Nicol T; Sidransky D
Int J Cancer; 2001 Aug; 93(3):424-9. PubMed ID: 11433409
[TBL] [Abstract][Full Text] [Related]
19. Performance indicators of organized cervical screening in Romagna (Italy).
Bucchi L; Falcini F; Schincaglia P; Desiderio F; Bondi A; Farneti M; Casadei Giunchi D; Serafini M; Canuti D; Caprara L; Sabbadini F; Monari F; Sassoli P
Eur J Cancer Prev; 2003 Jun; 12(3):223-8. PubMed ID: 12771561
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cervical smears in a Muslim population.
Wasti S; Ahmed W; Jafri A; Khan B; Sohail R; Hassan S
Ann Saudi Med; 2004; 24(3):189-92. PubMed ID: 15307457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
